Skip to content
The Nexus
DossierENTITY

BioOrbit

Coverage of BioOrbit in the Nexus archive.

Earliest in view: May 23 · 09:00 UTCMost recent: Jul 10 · 11:06 UTC
Co-mentioned in this coverage
CEOperson1cancer treatmentstopic1zero gravitytopic1SpaceXorganization1International Space Stationplace1Box-Etopic1cancer treatmenttopic1United Kingdomplace1protein crystalstopic1
Recent coverage
  • HEALTHJul 10 · 11:06 UTCBLOOMBERG
    BioOrbit CEO on Developing Cancer Treatments in Zero Gravity

    BioOrbit's CEO discusses the development of cancer treatments in zero gravity. The focus is on leveraging microgravity environments to advance medical research.

  • HEALTHMay 23 · 09:00 UTCTHE GUARDIAN TECH
    Final frontier for meds? UK startup sends drug-making into space

    A UK startup, BioOrbit, launched a drug-crystallisation technology unit called Box-E to the International Space Station via SpaceX to grow ultra-pure protein crystals. The goal is to develop self-injected cancer treatments that could save millions of lives.